Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway

Nature Medicine

Volumn 10, Issue 10, 2004, Pages 1067-1073

  Hanada, Reiko ^a,b   Teranishi, Hitoshi ^a   Pearson, James Todd ^c   Kurokawa, Mamoru ^d   Hosoda, Hiroshi ^c   Fukushima, Nobuhiro ^a   Fukue, Yoshihiko ^a   Serino, Ryota ^e   Fujihara, Hiroaki ^e   Ueta, Yoichi ^e   Ikawa, Masahito ^f   Okabe, Masaru ^f   Murakami, Noboru ^g   Shirai, Mikiyasu ^c   Yoshimatsu, Hironobu ^b   Kangawa, Kenji ^c   Kojima, Masayasu ^a  

^a KURUME UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; NEUROMEDIN U; NEUROPEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FEEDING BEHAVIOR; GENE EXPRESSION; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERPHAGIA; HYPOTHALAMUS; LOCOMOTION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOTTING, NORTHERN; BODY COMPOSITION; BODY TEMPERATURE REGULATION; BODY WEIGHT; CARRIER PROTEINS; ENERGY METABOLISM; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; HISTOLOGICAL TECHNIQUES; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ION CHANNELS; LEPTIN; LIVER; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; MITOCHONDRIAL PROTEINS; NEUROPEPTIDES; OBESITY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 7044229277     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1106     Document Type: Article

References (43)

1. Cummings, D.E. & Schwartz, M.W. Genetics and pathophysiology of human obesity. Annu. Rev. Med. 54, 453-471 (2003).
2. Marx, J. Cellular warriors at the battle of the bulge. Science 299, 846-849 (2003).
3. Kalra, S.P. et al. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20, 68-100 (1999).
4. Minamino, N., Kangawa, K. & Matsuo, H. Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 130, 1078-1085 (1985).
5. Ballesta, J. et al. Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 25, 797-816 (1988).
6. Howard, A.D. et al. Identification of receptors for neuromedin U and its role in feeding. Nature 406, 70-74 (2000).
7. Graham, E.S. et al. Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. J. Neurochem. 87, 1165-1173 (2003).
8. Fujii, R. et al. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J. Biol. Chem. 275, 21068-21074 (2000).
9. Kojima, M. et al. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem. Biophys. Res. Commun. 276, 435-438 (2000).
10. Nakazato, M. et al. Central effects of neuromedin U in the regulation of energy homeostasis. Biochem. Biophys. Res. Commun. 277, 191-194 (2000).
11. Hanada, R. et al. A role for neuromedin U in stress response. Biochem. Biophys. Res. Commun. 289, 225-228 (2001).
12. Nakahara, K. et al. The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. Biochem. Biophys. Res. Commun. 318, 156-161 (2004).
13. Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R. & Burn, P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549 (1995).
14. Pelleymounter, M.A. et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543 (1995).
15. Schwartz, M.W., Seeley, R.J., Campfield, L.A., Burn, P. & Baskin, D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98, 1101-1106 (1996).
16. Robinson, S.W., Dinulescu, D.M. & Cone, R.D. Genetic models of obesity and energy balance in the mouse. Annu. Rev. Genet. 34, 687-745 (2000).
17. Kurokawa, M., Akino, K. & Kanda, K. A new apparatus for studying feeding and drinking in the mouse. Physiol. Behav. 70, 105-112 (2000).
18. Nicholls, D.G. A history of UCP1. Biochem. Soc. Trans. 29, 751-755 (2001).
19. Masaki, T. et al. Corticotropin-releasing hormone-mediated pathway of leptin to regulate feeding, adiposity, and uncoupling protein expression in mice. Endocrinology 144, 3547-3554 (2003).
20. Schrauwen, P. & Hesselink, M. Uncoupling protein 3 and physical activity: the role of uncoupling protein 3 in energy metabolism revisited. Proc. Nutr. Soc. 62, 635-643 (2003).
21. Vidal-Puig, A.J. et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J. Biol. Chem. 275, 16258-16266 (2000).
22. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J. & Cone, R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168 (1997).
23. Abbott, C.R. et al. Investigation of the melanocyte stimulating hormones on food intake. Lack of evidence to support a role for the melanocortin-3- receptor. Brain. Res. 869, 203-210 (2000).
24. Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141 (1997).
25. Moussa, N.M. & Claycombe, K.J. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity. Obes. Res. 7, 506-514 (1999).
26. Egawa, M., Yoshimatsu, H. & Bray, G.A. Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissue. Neuroscience 34, 771-775 (1990).
27. Ivanov, T.R., Lawrence, C.B., Stanley, P.J. & Luckman, S.M. Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143, 3813-3821 (2002).
28. Ozaki, Y. et al. Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 143, 4320-4329 (2002).
29. Hanada, T. et al. Central actions of neuromedin U via corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 311, 954-958 (2003).
30. Wren, A.M. et al. Hypothalamic actions of neuromedin U. Endocrinology 143, 4227-4234 (2002).
31. Schwartz, M.W. et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46, 2119-2123 (1997).
32. Mizuno, T.M. & Mobbs, C.V. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140, 814-817 (1999).
33. Elmquist, J.K. & Flier, J.S. Neuroscience. The fat-brain axis enters a new dimension. Science 304, 63-64 (2004).
34. Schwartz, M.W., Peskind, E., Raskind, M., Boyko, E.J. & Porte, D., Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat. Med. 2, 589-593 (1996).
35. Caro, J.F. et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348, 159-161 (1996).
36. Friedman, J.M. & Halaas, J.L. Leptin and the regulation of body weight in mammals. Nature 395, 763-770 (1998).
37. Masaki, T., Yoshimatsu, H., Chiba, S., Watanabe, T. & Sakata, T. Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice. Diabetes 50, 376-384 (2001).
38. Withers, P.C. Measurement of VO2, VCO2, and evaporative water loss with a flow-through mask. J. Appl. Physiol. 42, 120-123 (1977).
39. Yamamoto, Y., Ueta, Y., Yamashita, H., Asayama, K. & Shirahata, A. Expressions of the prepro-orexin and orexin type 2 receptor genes in obese rat. Peptides 23, 1689-1696 (2002).
40. Nomura, M. et al. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice. J. Neuroendocrinol. 15, 1054-1061 (2003).
41. Yamamoto, Y. et al. Effects of food restriction on the hypothalamic prepro-orexin gene expression in genetically obese mice. Brain. Res. Bull. 51, 515-521 (2000).
42. Isse, T. et al. Effects of leptin on fasting-induced inhibition of neuronal nitric oxide synthase mRNA in the paraventricular and supraoptic nuclei of rats. Brain. Res. 846, 229-235 (1999).
43. Hanada, R. et al. Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system. Biochem. Biophys. Res. Commun. 268, 88-91 (2000).